Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Development of a Live Attenuated Rotavirus Vaccine HIC Model
NCT04123119Completed
- Sponsor
- Center for Infectious Disease Research in Zambia
- Start
- Jan 2019
- Primary completion
- May 2019
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Open-label, single-arm trial of rotavirus vaccine, live, oral in rotavirus infection, sponsored by Center for Infectious Disease Research in Zambia. Primary endpoint: Measurement of serum Rotavirus-IgA and Rotavirus-IgG at 3 months. Started Jan 2019; status: completed.
02
Drugs
rotavirus vaccine, live, oral
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT04123119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04123119.